Lelanya B Kearns, MD
Obstetrics/Gynecology · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Office
- 1
Offices
1 location · El Camino Health Medical Network LLC · 202 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health · Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kearns’s office at (408) 866-4070 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A90034 · Current
Licensed to practise in California · since 2005 · expires 2027-02-28 · University of Kentucky College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$29,208
Medicare paid this office $29,208 for 193 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 82 | $8,286 | $80 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 86 | $4,213 | $49 |
| New patient visit (30+ min) | 36 | $3,587 | $100 |
| Return visit (30+ min) | 24 | $3,109 | $104 |
| New patient visit (45+ min) | 19 | $2,846 | $150 |
See all 9 services
| Short return visit (20+ min) | 82 | $8,286 | $80 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 86 | $4,213 | $49 |
| New patient visit (30+ min) | 36 | $3,587 | $100 |
| Return visit (30+ min) | 24 | $3,109 | $104 |
| New patient visit (45+ min) | 19 | $2,846 | $150 |
| Short return visit | 38 | $2,280 | $52 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 26 | $1,528 | $59 |
| Biopsy of lining of uterus | 14 | $1,177 | $84 |
| Urinalysis, manual test | 16 | $61 | $3 |
Who their Medicare patients are
193 Original Medicare patients in 2024. Average age 71 · Women 100% · Also on Medicaid 9% · Health risk score 0.83. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 64% · Diabetes 26% · Coronary heart disease 19% · Depression 17% · Chronic kidney disease 15% · Atrial fibrillation 13% · COPD 10% · Cancer 9% · Heart failure 8%.
The office billed $115,762, Medicare allowed $38,504 and paid $29,208; for 404 services of 22 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 193 | 404 | 71 | 0.83 | $115,762 | $29,208 |
| 2023 | 140 | 227 | 71 | 0.80 | $64,860 | $16,418 |
| 2022 | 139 | 305 | 73 | 0.79 | $79,744 | $19,781 |
| 2021 | 91 | 170 | 72 | 0.73 | $38,053 | $10,923 |
| 2020 | 46 | 105 | 71 | 0.98 | $22,581 | $6,438 |
| 2019 | 76 | 137 | 71 | 1.00 | $54,554 | $10,469 |
| 2018 | 69 | 122 | 70 | 0.88 | $47,026 | $8,108 |
| 2017 | 23 | 45 | 68 | 0.84 | $10,161 | $2,687 |
| 2016 | 36 | 70 | 70 | 0.94 | $28,028 | $5,408 |
| 2015 | 33 | 83 | 70 | 1.21 | $17,660 | $5,966 |
| 2014 | 21 | 47 | 69 | 0.81 | $10,141 | $3,014 |
| 2013 | 31 | 56 | 69 | 1.06 | $6,873 | $3,442 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Short return visit (20+ min) | 35 | $3,527 | $73 |
| New patient visit (30+ min) | 32 | $2,988 | $93 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 52 | $2,536 | $49 |
| Return visit (30+ min) | 12 | $1,623 | $125 |
| Short return visit | 25 | $1,361 | $49 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 15 | $855 | $57 |
2022: 8 services
| Short return visit (20+ min) | 37 | $5,211 | $80 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 64 | $3,111 | $49 |
| New patient visit (30+ min) | 21 | $1,978 | $94 |
| Return visit (30+ min) | 15 | $1,803 | $113 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 28 | $1,572 | $56 |
| New patient visit (15+ min) | 22 | $1,143 | $52 |
| Short return visit | 21 | $1,066 | $46 |
| Urinalysis, manual test | 15 | $55 | $3 |
2021: 4 services
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 46 | $2,230 | $48 |
| Short return visit (20+ min) | 19 | $1,926 | $80 |
| Short return visit | 15 | $1,511 | $50 |
| New patient visit (15+ min) | 14 | $971 | $69 |
2020: 2 services
| Short return visit (20+ min) | 13 | $2,102 | $70 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 14 | $672 | $48 |
2019: 3 services
| Short return visit (20+ min) | 28 | $2,891 | $67 |
| New patient visit (30+ min) | 25 | $2,579 | $103 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 19 | $897 | $47 |
2018: 3 services
| Short return visit (20+ min) | 31 | $2,543 | $67 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 35 | $1,563 | $45 |
| Return visit (30+ min) | 12 | $1,299 | $100 |
2016: 2 services
| Short return visit (20+ min) | 13 | $1,408 | $56 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 14 | $609 | $44 |
2015: 2 services
| Short return visit (20+ min) | 19 | $2,304 | $66 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 11 | $523 | $48 |
2014: 1 service
| Short return visit (20+ min) | 12 | $936 | $62 |
2013: 1 service
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 20 | $908 | $45 |
Drugs they prescribed that Part D paid
$29,140
Pharmacies billed $29,140 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 360) in 2024. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
306 generic and 54 brand-name prescriptions · $29,140 in drug cost · 43 antibiotic prescriptions to 24 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol | 101 | $5,642 | $56 |
| Yuvafem | 11 | $2,062 | $187 |
| Estradiol (Twice Weekly) | 15 | $1,584 | $106 |
| Clobetasol Propionate | 24 | $432 | $18 |
| Progesterone | 11 | $305 | $28 |
See all 12 drugs
| Estradiol | 101 | $5,642 | $56 |
| Yuvafem | 11 | $2,062 | $187 |
| Estradiol (Twice Weekly) | 15 | $1,584 | $106 |
| Clobetasol Propionate | 24 | $432 | $18 |
| Progesterone | 11 | $305 | $28 |
| Nitrofurantoin Mono-Macro | 13 | $222 | $17 |
| Valacyclovir | 21 | $184 | $9 |
| Alendronate | 12 | $161 | $13 |
| Fluconazole | 29 | $148 | $5 |
| Metronidazole | 18 | $118 | $7 |
| Misoprostol | 15 | $57 | $4 |
| Paroxetine | 11 | $30 | $3 |
Year by year
| 2024 | 360 | 132 | 0% (0) | 15% | $29,140 |
| 2023 | 239 | 90 | 0% (0) | 16% | $21,270 |
| 2022 | 216 | 81 | 0% (0) | 24% | $21,848 |
| 2021 | 112 | 50 | 0% (0) | 24% | $11,723 |
| 2020 | 102 | 36 | 0% (0) | 23% | $9,746 |
| 2019 | 115 | 49 | 0% (0) | None | $10,019 |
| 2018 | 55 | 33 | 0% (0) | None | $3,040 |
| 2017 | 56 | 23 | None | 21% | $3,336 |
| 2016 | 51 | 21 | None | None | $1,564 |
| 2015 | 77 | 27 | 0% (0) | None | $3,554 |
| 2014 | 64 | 22 | 0% (0) | 27% | $8,316 |
| 2013 | 80 | 21 | None | 43% | $8,445 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Estradiol | 46 | $4,064 | $88 |
| Yuvafem | 30 | $3,985 | $133 |
| Estradiol (Twice Weekly) | 11 | $2,304 | $209 |
| Progesterone | 11 | $432 | $39 |
| Valacyclovir | 13 | $203 | $16 |
| Fluconazole | 12 | $153 | $13 |
| Alendronate | 19 | $141 | $7 |
| Metronidazole | 12 | $125 | $10 |
| Misoprostol | 12 | $23 | $2 |
2022: 7 drugs
| Estring | 12 | $5,973 | $498 |
| Premarin | 11 | $5,404 | $491 |
| Estradiol | 45 | $3,356 | $75 |
| Estradiol (Twice Weekly) | 13 | $1,428 | $110 |
| Progesterone | 12 | $324 | $27 |
| Alendronate | 13 | $207 | $16 |
| Metronidazole | 11 | $75 | $7 |
2021: 1 drug
| Alendronate | 19 | $281 | $15 |
2020: 3 drugs
| Estradiol | 13 | $1,559 | $120 |
| Clobetasol Propionate | 11 | $350 | $32 |
| Alendronate | 16 | $258 | $16 |
2019: 4 drugs
| Estradiol | 15 | $3,010 | $201 |
| Clobetasol Propionate | 11 | $401 | $36 |
| Fluconazole | 11 | $197 | $18 |
| Alendronate | 14 | $154 | $11 |
2017: 1 drug
| Alendronate | 13 | $134 | $10 |
2016: 2 drugs
| Alendronate | 24 | $277 | $12 |
| Estradiol | 11 | $138 | $13 |
2015: 1 drug
| Alendronate | 35 | $333 | $10 |
2014: 1 drug
| Alendronate | 27 | $378 | $14 |
2013: 3 drugs
| Actonel | 12 | $3,028 | $252 |
| Ortho Evra | 12 | $1,441 | $120 |
| Alendronate | 27 | $342 | $13 |
Money from drug and device companies
$75 in 2025
| 2025 | 1 | 3 | None | $75 |
| 2024 | 1 | 1 | None | $26 |
| 2019 | 1 | 1 | None | $34 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Exact Sciences | Cologuard Collection Kit | $75 | 3 payments
|
See all 3 published payments
| Exact Sciences | Meals · 2025-10-14 | Cologuard Collection Kit | $26 |
| Exact Sciences | Meals · 2025-04-29 | Cologuard Collection Kit | $28 |
| Exact Sciences | Meals · 2025-01-14 | Cologuard Collection Kit | $20 |
See earlier years (2024, 2019)
2024: $26
| Exact Sciences | Cologuard Collection Kit | $26 | 1 payment
|
2019: $34
| Merck Sharp & Dohme | Nexplanon | $34 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1356398697
- Licence
- CA A90034, KY 38880California A90034: Current · expires 2027-02-28
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- IN 200501440, KY 64086325, OH 2513766
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 2585 Samaritan Dr, San Jose, CA, 95124
- NPI first listed
- 2006-05-30
- NPI last updated
- 2020-11-30
- NPI record certified
- 2020-11-30
This is when the NPI record was last certified, not a medical board exam.